Skip to content

Effects of prebiotic-rich dietary intervention on metabolic abnormalities and hyperandrogenism status in patients with polycystic ovary syndrome

Effects of prebiotic-rich dietary intervention on metabolic abnormalities and hyperandrogenism status in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122645
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

Intervention group:Prebiotic-rich diet plan
Control group:Regular diet plan for patients with PCOS

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University, Western Guangdong Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Female individuals aged 18 - 40; 2.Meets the Rotterdam PCOS diagnostic criteria (satisfying at least 2 out of the following 3 items: (1) Infrequent ovulation or no ovulation; (2) Clinical and/or biochemical hyperandrogenism; (3) Ultrasound showing polycystic ovarian changes and excluding other causes); 3.Within the past 3 months, has not taken probiotics/probiotics supplements, antibiotics, hormonal drugs (including oral contraceptives, glucocorticoids, etc.), metformin, carbamazepine and other antiepileptic drugs; 4.Voluntarily participates and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Combined diabetes (type 1 or type 2), Cushing's syndrome, congenital adrenal hyperplasia, hyperprolactinemia, abnormal thyroid function; 2.Diagnosis or suspected malignant tumor; 3.Diagnosis of epilepsy or mental psychological disorders; 4.Gastrointestinal disease history (such as inflammatory bowel disease, irritable bowel syndrome, chronic diarrhea), history of gastrointestinal surgery; 5.Pregnant or lactating; 6.Severe heart, liver, or kidney dysfunction; 7.Participating in other clinical trials; 8.Known to be allergic or intolerant to the recommended foods in the study (such as onions, garlic, etc.).

Design outcomes

Primary

MeasureTime frame
HOMA-IR;Free androgen index;oral glucose tolerance release test;Four lipid profile items(TC, TG, HDL-C, LDL-C);totol testosterone;follicle-stimulating hormone;luteinizing hormone;estrogen;progesterone;prolactin;sex hormone binding globulin;thyroid stimulating hormone;

Secondary

MeasureTime frame
modified Ferriman-Gallwey hairiness score;height;weight;body mass index;waist hip ratio;blood pressure;Severity grading of acne;16S rRNA sequencing of fecal samples;proinflammatory cytokine;Anti-inflammatory cytokines;

Countries

China

Contacts

Public ContactHui Li

The Sixth Affiliated Hospital of Sun Yat-sen University, Western Guangdong Hospital / Xinyi People's Hospital

lihui265@mail.sysu.edu.cn+86 198 8088 8008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026